Haleon

Last updated

Haleon plc
Company type Public limited company
ISIN GB00BMX86B70
Industry
Predecessors
Founded18 July 2022;2 years ago (2022-07-18)
Headquarters Weybridge, England, United Kingdom
Area served
Worldwide
Key people
Products
Brands
RevenueIncrease2.svg £11,302 million (2023) [1]
Increase2.svg £1,996 million (2023) [1]
Decrease2.svg £1,111 million (2023) [1]
Total assets Decrease2.svg £34,055 million (2023) [1]
Total equity Increase2.svg £16,729 million (2023) [1]
Number of employees
24,000 (2023) [2]
Website www.haleon.com

Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. [3] It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers and Centrum vitamins. [4] The company is a global leader in over the counter medicines with a 7.3 percent market share. [5]

Contents

Haleon was established on 18 July 2022 as a corporate spin-off from GSK. [6]

Sir David Lewis is chairman, with Brian McNamara as CEO. [7] Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Annual sales amounted to around £10 billion across 120 markets in 2020. [5]

History

GSK and Pfizer merged their consumer healthcare businesses in 2019. [8] [9] GSK owned just over two thirds of the joint venture, and Pfizer held the remainder. [8]

GSK announced plans to spin-off Haleon in 2018, in order to give the "tired drugmaker extra focus and firepower by gearing up and hiving off the consumer division". [10]

Unilever offered £50 billion for the business in 2022, in a bid which GSK rejected. [11] Nestlé examined the possibility of a bid in conjunction with Reckitt. [12]

In October 2023, GSK reduced its ownership share in Haleon to just over 7.4%, [13] and again in January 2024 down to 4.2%. [14]

The Lamisil antifungal brand was sold to Karo Healthcare AB for £235 million in August 2023; the transaction was completed on November 2023. [15] [16]

The ChapStick lip care brand was sold to Yellow Wood Partners for £401 million in 2024. [17]

In March 2024, Pfizer reduced its stake in Haleon from 32% to 24% by selling 630 million shares in a public offering. [18]

In April 2024 Haleon announced that it planned to close its British factory in Maidenhead. [19] Toothpaste manufacturing would be relocated to Slovakia, with mouthwash production outsourced to a third-party. [20]

In June 2024, the company announced the sale of its non-US nicotine brands to Dr. Reddy's Laboratories in a deal worth £500 million. [21] [22]

Operations

Oral health accounted for 28.5 percent of revenue in 2021. [23]

Brands

A selection of Aquafresh toothpaste and toothbrushes produced by Haleon Aquafresh - GSK.jpg
A selection of Aquafresh toothpaste and toothbrushes produced by Haleon

Current

Brands include: [24]

  • Abreva (Docosanol)
  • Advil (Ibuprofen)
  • alli (Orlistat)
  • Anadin (pain relief)
  • Aquafresh (oral healthcare)
  • Astring-o-Sol (oral healthcare)
  • Be-Total (leader in vitamins market in Italy)
  • Beechams Cold & Flu and Night/Day Nurse (cold and flu treatments)
  • Biotene (oral healthcare)
  • Boost (nutritional)
  • Breathe Right (respiratory)
  • Centrum (vitamins and naturals)
  • Cetebe (vitamins and naturals)
  • Chlorhexamed (oral healthcare)
  • Cholinex (analgesics and respiratory tract)
  • Citrucel (gastrointestinal)
  • Coldrex (cold and flu treatment)
  • Commit Lozenge (smoking cessation)
  • Committed Quitters (nicotine replacement)
  • Corega (oral healthcare)
  • Corsodyl (oral healthcare)
  • Crocin (analgesics and respiratory tract)
  • Dr. Best (oral healthcare)
  • Emergen-C
  • ENO (gastrointestinal)
  • Eumovate (dermatological)
  • Excedrin
  • Fenistil
  • Fenbid (analgesics and respiratory tract)
  • Flonase (fluticasone propionate)
  • Foodles (noodles), origin: India
  • Formigran (analgesic/triptan)
  • Grand-PA (headache/toothache/pain and fever)
  • Hinds (dermatological)
  • Junior Horlicks (nutritional)
  • Imedeen
  • Iodex (pain relief)
  • Iodosan (cold and flu treatment)
  • Macleans (oral healthcare)
  • Maltova (nutritional)
  • Maxinutrition (nutritional)
  • Med-Lemon (hot, cold and flu medication)
  • Medacalm (vitamins and naturals)
  • Nexium Control (esomeprazole)
  • Nicorette (nicotine replacement)
  • Nicotinell
  • Night Nurse (cold and flu remedy)
  • NiQuitin CQ/ Nicoderm CQ/ Nicabate (nicotine replacement)
  • Odol (oral healthcare)
  • Odol-med3 (oral healthcare)
  • Os-cal (oral healthcare)
  • Otrivin/Otrivine (xylometazoline)
  • Panadeine (analgesics and respiratory tract)
  • Panadol/Panodil (analgesics and respiratory tract)
  • parodontax (oral healthcare)
  • Piriton/Piriteze/Pirinase (anti-allergy)
  • Polident (oral healthcare)
  • Poligrip Ultra (oral healthcare)
  • Robitussin (respiratory)
  • Rutinoscorbin (vitamins and naturals)
  • Scott's Emulsion (vitamins and naturals)
  • Sensodyne (oral healthcare)
  • Shumitect (oral healthcare)
  • Solpadeine (analgesics and respiratory tract)
  • Super Poligrip (oral healthcare)
  • Super Wernet's (oral healthcare)
  • Synthol (oral healthcare)
  • Theraflu (Respiratory)
  • Tums (gastrointestinal)
  • Viva (vitamins and naturals), origin: Nepal
  • Voltaren/Voltarol (anti inflammatory)
  • Zovirax (dermatological)

Divested

  • Lamisil (terbinafine) (sold to Karo Healthcare in 2023)
  • ChapStick (sold to Yellow Wood Partners in 2024)

Related Research Articles

<span class="mw-page-title-main">GSK plc</span> UK healthcare company

GSK plc is a British multinational pharmaceutical and biotechnology company with global headquarters in London. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.

<span class="mw-page-title-main">Horlicks</span> Sweet malted milk hot drink powder

Horlicks is a British sweet malted milk hot drink powder developed by founders James and William Horlick. It was first sold as "Horlick's Infant and Invalids Food", soon adding "aged and travellers" to their label. In the early 20th century, it was sold as a powdered meal replacement drink mix.

<span class="mw-page-title-main">Respiratory syncytial virus</span> Species of virus

Respiratory syncytial virus (RSV), also called human respiratory syncytial virus (hRSV) and human orthopneumovirus, is a contagious virus that causes infections of the respiratory tract. It is a negative-sense, single-stranded RNA virus. Its name is derived from the large cells known as syncytia that form when infected cells fuse.

<span class="mw-page-title-main">Upper respiratory tract infection</span> Medical condition

An upper respiratory tract infection (URTI) is an illness caused by an acute infection, which involves the upper respiratory tract, including the nose, sinuses, pharynx, larynx or trachea. This commonly includes nasal obstruction, sore throat, tonsillitis, pharyngitis, laryngitis, sinusitis, otitis media, and the common cold. Most infections are viral in nature, and in other instances, the cause is bacterial. URTIs can also be fungal or helminthic in origin, but these are less common.

ChapStick is a brand name of lip balm owned by Suave Brands Company, a subsidiary of private equity firm Yellow Wood Partners, and is used in many countries worldwide. It is intended to help treat and prevent chapped lips, hence the name. Many varieties also include sunscreen in order to prevent sunburn.

<span class="mw-page-title-main">Cefuroxime axetil</span> Chemical compound

Cefuroxime axetil, sold under the brand name Ceftin among others, is a second generation oral cephalosporin antibiotic.

Actifed is a registered trademark for a combination antihistamine and nasal decongestant medication used for cold and allergy symptoms. Actifed was developed in 1958 by Burroughs Wellcome & Company, later Haleon.

<span class="mw-page-title-main">Perrigo</span> Irish tax-registered pharmaceutical

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.

Emergen-C is an effervescent, powdered drink mix vitamin supplement manufactured by Alacer Corp. The Emergen-C product line was introduced in 1978. Alacer was established as a private company in 1972, focusing on vitamin supplements containing vitamin C. The company was acquired by Pfizer in 2012. In 2019, Pfizer consumer healthcare entered a joint venture with GSK. The brand is owned by Haleon since 18 July 2022.

Caltrate is a brand name calcium supplement sold by Haleon.

<span class="mw-page-title-main">Sensodyne</span> Dental hygiene product for sensitive teeth

Sensodyne is a brand name of toothpaste and mouthwash targeted at people with sensitive teeth. Sensodyne is owned by Haleon and is marketed under the name Shumitect in Japan.

<span class="mw-page-title-main">Beecham Group</span> Former British pharmaceutical company (1859–1989)

The Beecham Group plc was a British pharmaceutical company. It was once a constituent of the FTSE 100 Index. Founded by Thomas Beecham who opened the first factory in St Helens, Lancashire in 1859, Beecham focused on marketing the business by advertising in newspapers and using a network of wholesale agents in northern England and in London, rapidly building up the business. In August 1859 he created the slogan for Beecham's Pills: "Worth a guinea a box", considered to be the world's first advertising slogan, which helped the business become a global brand.

<span class="mw-page-title-main">Centrum (multivitamin)</span> Brand of multivitamins

Centrum is an American brand of multivitamins produced by Haleon. It was previously owned by Pfizer and GSK.

<span class="mw-page-title-main">Wyeth</span> American pharmaceutical company

Wyeth was a pharmaceutical company until it was purchased by Pfizer in 2009. The company was founded in Philadelphia, Pennsylvania, in 1860 as John Wyeth and Brother. Its headquarters moved to Collegeville, Pennsylvania, and Madison, New Jersey, before its headquarters were consolidated with Pfizer's in New York City after the 2009 merger.

Ibuprofen/paracetamol, sold under the brand name Combogesic among others, is a fixed-dose combination of two medications, ibuprofen, a non-steroidal anti-inflammatory drug (NSAID); and paracetamol (acetaminophen), an analgesic and antipyretic. It is available as a generic medication.

<span class="mw-page-title-main">Emma Walmsley</span> British businesswoman

Dame Emma Natasha Walmsley is the chief executive officer (CEO) of GlaxoSmithKline. She succeeded Sir Andrew Witty, who retired in March 2017. Before GSK, she worked for L'Oréal for 17 years, and was a non-executive director of Diageo until September 2016. She grew up in Barrow-in-Furness, Cumbria, England.

Parodontax is a brand name of toothpaste and mouthwash currently owned by Haleon, previously GSK.

A respiratory syncytial virus vaccine, or RSV vaccine, is a vaccine that protects against respiratory syncytial virus. RSV affects an estimated 64 million people and causes 160,000 deaths worldwide each year.

References

  1. 1 2 3 4 5 "Annual results 2023" (PDF). Haleon. Retrieved 29 February 2024.
  2. "Haleon plots massive layoffs in UK and beyond to save costs: report". Fierce Pharma. 13 July 2023. Retrieved 11 February 2024.
  3. "GSK announces independent Consumer Healthcare company is to be called Haleon | GSK". www.gsk.com. 22 February 2022. Retrieved 21 February 2023.
  4. Ralph, Alex (2 July 2022). "GlaxoSmithKline prepares to get back to basics with historic break-up". The Times . Retrieved 4 July 2022.
  5. 1 2 Cornell, Joe (15 July 2021). "GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022". Forbes . Retrieved 10 June 2022.
  6. "Prospectus" (PDF). GSK plc. p. 15. Archived from the original (PDF) on 1 June 2022. Retrieved 10 June 2022.
  7. Kleinman, Mark (3 May 2022). "GSK's £45bn Panadol and Sensodyne-maker Haleon in talks to hire banks". Sky News . Retrieved 10 June 2022.
  8. 1 2 Shane, Daniel (19 December 2018). "Advil meet Excedrin: Pfizer and GSK are merging their consumer healthcare businesses". CNN . Retrieved 10 June 2022.
  9. "Haleon Won't Indemnify Pfizer, GSK Over Zantac. Shares Are Up". Barron's. 20 September 2022. Retrieved 17 December 2022.
  10. Donnellan, Aimee (9 June 2022). "GSK castoff starts life with target on its back". Reuters . Retrieved 10 June 2022.
  11. Jolly, Jasper (19 January 2022). "Unilever will not increase £50bn offer for GSK consumer arm". The Guardian . Retrieved 10 June 2022.
  12. "Nestle Eyed Biggest-Ever Deal in Aborted Move for GSK Unit". Bloomberg News . 25 May 2022. Retrieved 10 June 2022.
  13. "GSK raises $1.1 billion from Haleon stake sale". Reuters. 6 October 2023. Retrieved 9 October 2023.
  14. "GSK raises $1.24 bln from latest Haleon stake sale". Reuters. 17 January 2024. Retrieved 18 January 2024.
  15. Healthcare, Karo (2 August 2023). "Karo Healthcare acquires the Global OTC brand Lamisil® from Haleon". Karo Healthcare. Retrieved 5 June 2024.
  16. Healthcare, Karo (1 November 2023). "Karo Healthcare completes the acquisition of the rights to the Global OTC brand Lamisil® from Haleon". Karo Healthcare. Retrieved 5 June 2024.
  17. Williams, Holly (25 January 2024). "Haleon offloads ChapStick lip balm brand in £401m deal". The Standard. Retrieved 20 February 2024.
  18. "Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24%". Yahoo Finance. 18 March 2024. Retrieved 19 March 2024.
  19. Briant, Nathan (30 April 2024). "Sensodyne maker set to cut 435 jobs". BBC News. Retrieved 8 May 2024.
  20. Mathews, Eva (30 April 2024). "Sensodyne-maker Haleon to shut UK plant, 435 jobs to go". Reuters. Retrieved 8 May 2024.
  21. Ralph, Alex (27 June 2024). "Haleon quits nicotine replacement with £500m sale of brands". www.thetimes.com. Retrieved 27 June 2024.
  22. "London Stock Exchange | London Stock Exchange". www.londonstockexchange.com. Retrieved 27 June 2024.
  23. "Update: Proposed demerger of the Consumer Healthcare business from GSK to form Haleon". GSK. 6 January 2022. Retrieved 10 June 2022.
  24. "Our Consumer Healthcare Brands". Haleon. Retrieved 19 July 2022.